• Brand Name: Turalio
  • Innovator Brand Name: Turalio
  • API: Pexidartinib
  • Packaging: 28/120 Capsules
  • Strength: 200mg
  • Manufacturer Name: Daiichi Sankyo Company, Ltd.
Get Price


Turalio (Pexidartinib Capsules)

Turalio (Pexidartinib) is used for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.

Dosage: The recommended turalio dose is 400 mg, administered twice daily on an empty stomach until the disease is progressive or unacceptable toxicity established. Swallow the capsules of turalio whole. Do not open, break, or chew the capsules. If a patient vomits or misses a dose, instruct the patient to take the next dose at its scheduled time.

Side Effects: The most commonly reported pexidartinib side effects include:

  • Increased lactate dehydrogenase
  • Increased aspartate aminotransferase
  • Hair color changes
  • Fatigue
  • Decreased neutrophils
  • Increased cholesterol
  • Increased alkaline phosphatase
  • Decreased lymphocytes
  • Eye edema
  • Decreased hemoglobin
  • Rash
  • Dysgeusia
  • Decreased phosphate
  • Increased alanine aminotransferase

Warnings and Precautions:

  • Permanently discontinue turalio uses in such patients who are unable to tolerate 200 mg orally twice in a day.
  • Do not breastfeed during treatment with pexidartinib and for at least seven days following your final dose of pexidartinib.
  • The pexidartinib 200 mg may affect fertility in females and males, which may affect your ability to have children. Talk to your health specialist if you have concerns about fertility.
  • Avoid taking proton pump inhibitor medicines (PPIs) & St. John’s wort during therapy with turalio capsules because they can affect how this drug works.
  • Females of reproductive potential are advised to use effective contraception during therapy with pexidartinib and for 30 days following the final dose.

More Info

Storage: Turalio 200 Mg Capsules should be stored at room temperature between 68°F to 77°F (20°C to 25°C). Keep the container closed tightly. This medication comes with a drying agent (desiccant) in the container. Keep the desiccant in the container. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the TURALIO at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the TURALIO Capsules. Buying Procedure: In order to buy TURALIO, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusion: Pexidartinib treatment is the first systemic therapy introduced for recipients with symptomatic TGCT linked with the severe morbidity or functional limitations not amenable to improvement with surgery. The unique mode of action of the medication, a TKI that inhibits CSF-1 receptors, has shown increased response rates when compared with other agents studied.


What is Turalio? Turalio is a kinase inhibitor intended to treat adults with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery. What does Turalio contain as an active substance? The medication Turalio specifically contains the active substance Pexidartinib. How is Pexidartinib supplied? Pexidartinib is supplied as Capsules, 200 mg for oral administration. How much does turalio cost? The turalio price in India usually may vary depending on the wholesaler/pharmacy you visit and of course the brand you choose. What is the best price for Pexidartinib? Please contact Toll-free: +91 1800 889 1064|+919310090915 for pexidartinib price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements. Can I get Turalio (Pexidartinib) even if I am not based in India? The Indian Pharma helps patients in accessing or importing Turalio (Pexidartinib), not approved in their home country against the legitimate prescription and in conformity with all local laws and regulations of their home country.